Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging.
暂无分享,去创建一个
Z. Fayad | Reiko Ohmori | Y. Momiyama | H. Taniguchi | A. Yonemura | Haruo M D Nakamura | F. Ohsuzu | M. Kusuhara | Shojiro Sawada | S. Tamai | M. Ayaori | T. Kihara | M. Nagata | M. Ogura | N. Iwamoto | K. Higashi | H. Nakamura
[1] Robert H. Wilkins,et al. Autopsy Studies in Atherosclerosis: I. Distribution and Severity of Atherosclerosis in Patients Dying without Morphologic Evidence of Atherosclerotic Catastrophe , 1959 .
[2] Paul Schoenhagen,et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. , 2004, JAMA.
[3] J. Schaper,et al. Hypertension and atherosclerosis in cholesterol-fed rabbits. Part 1. Mild, two-kidney, one-clip Goldblatt hypertension treated with enalapril. , 1986, Atherosclerosis.
[4] K R Maravilla,et al. Effects of Prolonged Intensive Lipid-Lowering Therapy on the Characteristics of Carotid Atherosclerotic Plaques In Vivo by MRI: A Case-Control Study , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[5] V. Fuster,et al. High resolution ex vivo magnetic resonance imaging of in situ coronary and aortic atherosclerotic plaque in a porcine model. , 2000, Atherosclerosis.
[6] M. Trip,et al. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomised, double-blind trial , 2001, The Lancet.
[7] W H Baker,et al. Elastolytic and collagenolytic studies of arteries. Implications for the mechanical properties of aneurysms. , 1984, Archives of surgery.
[8] V. Fuster,et al. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. , 1996, Circulation.
[9] David A Bluemke,et al. Using MRI to assess aortic wall thickness in the multiethnic study of atherosclerosis: distribution by race, sex, and age. , 2004, AJR. American journal of roentgenology.
[10] C. Tribouilloy,et al. Relation between low-density lipoprotein cholesterol and thoracic aortic atherosclerosis. , 1999, The American journal of cardiology.
[11] Allen J. Taylor,et al. ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: A Randomized Trial Comparing the Effects of Atorvastatin and Pravastatin on Carotid Intima Medial Thickness , 2002, Circulation.
[12] V. Fuster,et al. Lipid Lowering by Simvastatin Induces Regression of Human Atherosclerotic Lesions: Two Years’ Follow-Up by High-Resolution Noninvasive Magnetic Resonance Imaging , 2002, Circulation.
[13] J. Schaper,et al. Hypertension and atherosclerosis in cholesterol-fed rabbits. II. One-kidney, one clip Goldblatt hypertension treated with nifedipine. , 1987, Atherosclerosis.
[14] V. Fuster,et al. In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. , 2000, Circulation.
[15] D. Reed,et al. Are Aortic Aneurysms Caused by Atherosclerosis? , 1992, Circulation.
[16] A. Zwinderman,et al. Regression of carotid and femoral artery intima-media thickness in familial hypercholesterolemia: treatment with simvastatin. , 2003, Archives of internal medicine.
[17] Thomas Weber,et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. , 2004, The New England journal of medicine.
[18] C. J. Schwartz,et al. Observations on Localization of Arterial Plaques , 1962, Circulation research.
[19] J. Strong,et al. Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. The PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[20] René M. Botnar,et al. Scan reproducibility of magnetic resonance imaging assessment of aortic atherosclerosis burden. , 2001, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[21] Z. Fayad,et al. In vivo magnetic resonance evaluation of associations between aortic atherosclerosis and both risk factors and coronary artery disease in patients referred for coronary angiography. , 2004, American heart journal.
[22] Kathleen M. Weil,et al. Simvastatin Lowers C-Reactive Protein Within 14 Days: An Effect Independent of Low-Density Lipoprotein Cholesterol Reduction , 2002, Circulation.
[23] A. Simon,et al. Risk factors and early extracoronary atherosclerotic plaques detected by three-site ultrasound imaging in hypercholesterolemic men. Prévention Cardio-vasculaire en Médecine du Travail METRA Group. , 1991, Archives of internal medicine.
[24] M. Pfeffer,et al. Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein , 1999 .
[25] A. Zwinderman,et al. B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS). , 1998, Journal of the American College of Cardiology.
[26] A. Simon,et al. Risk Factors and Early Extracoronary Atherosclerotic Plaques Detected by Three-Site Ultrasound Imaging in Hypercholesterolemic Men , 1991 .
[27] V. Fuster,et al. Effects of Lipid-Lowering by Simvastatin on Human Atherosclerotic Lesions: A Longitudinal Study by High-Resolution, Noninvasive Magnetic Resonance Imaging , 2001, Circulation.
[28] Samin K. Sharma,et al. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. , 2000, Circulation.
[29] V. Fuster,et al. Serial in vivo MRI documents arterial remodeling in experimental atherosclerosis. , 2000, Circulation.
[30] V. Fuster,et al. Atherosclerotic aortic component quantification by noninvasive magnetic resonance imaging: an in vivo study in rabbits. , 2001, Journal of the American College of Cardiology.